How much weight do people regain after stopping Ozempic?

The STEP-1 trial extension reported that participants regained roughly two-thirds of their prior weight loss within one year of stopping semaglutide. The STEP-4 trial showed that switching to placebo after 20 weeks of treatment produced a 14.8 percentage point difference in body weight versus continued treatment over the next 48 weeks. The exact amount any individual regains depends heavily on protein intake, resistance training, and overall food environment during the transition.

What is the single most important supplement after stopping a GLP-1?

Protein is not technically a supplement, but if you have to pick one thing it is protein at 1.4 to 2.0 g per kg of body weight per day, most often hit by adding 1 to 2 protein shakes per day to a normal diet. After protein, the highest-evidence supplement is creatine monohydrate at 5 g per day, paired with resistance training 2 to 3 times per week.

Should I taper off Ozempic or stop cold?

This is a clinical decision for the prescriber. Some practitioners taper the dose down over several weeks; others stop directly. The supplement protocol described here applies in either case. The biologically relevant transition (appetite rebound, gastric emptying normalizing) happens over weeks regardless of how the medication is discontinued.

Will berberine prevent weight regain after Ozempic?

No. Berberine has small effects on glucose control and modest effects on weight in people with metabolic dysfunction. It is not a replacement for a GLP-1 medication and the effect sizes are not comparable. It can be a reasonable adjunct for someone whose insulin sensitivity was the original concern, but framing it as a 'natural Ozempic' overstates the evidence substantially.

Do I need bone density testing after stopping a GLP-1?

It is worth asking about, especially for older women and anyone who lost more than 15% of body weight during treatment. The literature on GLP-1 medications and bone density is still developing, with several studies showing measurable bone loss during treatment. A DXA scan before stopping (and ideally one before starting) gives a baseline to work from. This is a conversation for your prescriber.

Can I take creatine while still on Ozempic?

Yes. There is no interaction between creatine and any GLP-1 medication, and the case for taking creatine is arguably stronger during treatment (when caloric intake is suppressed and muscle loss is most active) than after. See our piece on creatine for GLP-1 users for the full breakdown.

What about protein shakes if I am still not very hungry?

Liquid protein is often the most practical solution during the early transition because appetite is still partly suppressed but the protein target is now higher than it was during treatment. Whey isolate at 25 to 30 g per serving, twice per day on top of normal meals, closes most of the gap for a 150 to 200 pound person. Casein before bed is a reasonable third dose for those who can tolerate it.

Are there any supplements I should specifically avoid during the transition?

High-stimulant 'fat burner' products are a poor choice because they do not solve the underlying issue (appetite rebound) and add cardiovascular and sleep stress during a window that is already metabolically demanding. 'GLP-1 booster' formulas marketed for this exact transition rarely have evidence supporting the combined formula. CLA, garcinia, and raspberry ketones lack quality evidence for weight maintenance.

Supplements After Stopping Ozempic: The GLP-1 Transition (2026)

Coming off a GLP-1 medication (semaglutide as Ozempic or Wegovy, tirzepatide as Mounjaro or Zepbound, liraglutide as Saxenda) is not the same biological event as starting a new diet. You are not asking the body to lose more weight. You are asking it to hold the weight loss already achieved while two specific physiological changes reverse: appetite signaling and gastric emptying both normalize, usually over a window of 4 to 12 weeks after the last dose.

The clinical data on what happens during that window is now reasonably clear. The STEP-1 trial extension (Wilding 2022) followed participants for one year after stopping semaglutide and reported that they regained roughly two-thirds of their prior weight loss. The STEP-4 trial (Rubino 2021) in JAMA randomized people to either continue semaglutide or switch to placebo after 20 weeks of treatment, and the placebo group gained back 6.9% of body weight in the next 48 weeks while the continuation group lost another 7.9%, a 14.8 percentage point difference. The mechanism is not mysterious: when you remove the appetite suppression, calorie intake rises back toward pre-treatment levels, and the underlying weight-set-point biology has not been retrained.

Supplements do not change that biology. What they can do is support muscle retention, bone health, and metabolic stability during the transition, so that what you keep is closer to the body composition you wanted. This piece covers the three priorities supported by the strongest evidence, the secondary tier worth considering with appropriate hedging, and what to skip.

Note on framing: nothing in this piece is intended to treat, prevent, or manage weight regain as a clinical outcome. The evidence base for the supplements covered here is around supporting normal muscle, bone, and metabolic function. Decisions about how to come off a GLP-1 medication should be made with the prescriber who put you on it.

What Actually Changes When You Stop

Four physiological shifts matter for the supplement conversation:

Appetite signaling rebounds. Ghrelin (the hunger hormone) and the brain's hedonic food signals return to pre-treatment baseline over several weeks. Most users describe a noticeable "food noise" return by week 4 to 8 after the last dose.
Gastric emptying speeds up. GLP-1 medications slow gastric emptying, which contributes to fullness. That reverses over a few weeks, and meals feel smaller faster.
Lean mass loss is now permanent unless rebuilt. Body composition imaging studies on GLP-1 users consistently show that 25 to 40% of weight loss is lean tissue. None of that comes back automatically when you stop. It has to be rebuilt with protein and training.
Bone mineral density may be lower. Several smaller studies have observed bone loss during GLP-1 treatment, particularly in older adults and women. The evidence is mixed and the long-term consequence is still being characterized, but the direction of the signal suggests post-treatment bone support is worth considering for higher-risk groups.

The Three Priorities (In Order)

1. Protein at 1.4 to 2.0 g per kg of body weight per day

This is the single highest-impact intervention. The protein literature for older adults and people in caloric flux is consistent: intakes above the standard 0.8 g/kg RDA are needed to preserve muscle, and the PROT-AGE position paper (Bauer et al., 2013) recommends 1.0 to 1.2 g/kg as a floor for healthy older adults, with 1.2 to 1.5 g/kg for those with acute or chronic illness, and higher for those who are exercising. For someone in active muscle-rebuilding mode after a GLP-1 course, the upper end of that range (1.4 to 2.0 g/kg) is the relevant target.

Concretely, that means 100 to 140 g of protein per day for a 160-pound person, or 130 to 180 g for a 200-pound person. Most GLP-1 users were averaging 60 to 80 g during treatment because total food intake was suppressed. Doubling that is the work of the transition.

Whey protein isolate is the most practical tool for closing the gap. Casein is a reasonable alternative for evening dosing because of its slower digestion. Plant-based blends work but require slightly higher total intake because of lower leucine content per gram. Our GLP-1 protein powder guide covers specific product picks, and the whey protein isolate profile covers third-party testing and dosing details.

2. Resistance Training (Not a Supplement, but the Foundation)

This is not optional. Protein without resistance training in older adults produces only modest muscle preservation. Resistance training without protein produces only modest hypertrophy. The two together are the only intervention with strong evidence for rebuilding lean mass after weight loss. Two to three sessions per week of compound movements (squat, hinge, push, pull) at progressive load is the minimum effective dose. Bodyweight or dumbbell work is fine if barbells are not accessible.

Including this here because every supplement decision that follows has a much larger effect when training is present and a much smaller effect when it is not. The creatine and protein literature both assume training as the substrate.

3. Creatine Monohydrate at 5 g per day

Creatine is the cheapest and best-evidenced supplement for supporting muscle in this exact context (caloric flux, possible reduced training quality during early transition, older adults at risk for sarcopenia). The 2021 Forbes meta-analysis in Nutrients showed that creatine combined with resistance training produces meaningful gains in lean tissue mass in older adults regardless of dosing strategy, and the 2021 ISSN review (Antonio et al.) covers the broader body of evidence for creatine's safety and lean mass effects.

The protocol is simple: 5 g per day of creatine monohydrate, every day, no loading needed, no cycling. For users above 200 pounds, 7 to 10 g per day. See our creatine for GLP-1 users piece for the full case (the same logic applies during treatment and after).

The Secondary Tier (Worth Considering, With Hedging)

Vitamin D3, possibly with K2, for bone support

If you had your vitamin D status checked during the year leading up to or during treatment and it was low, this is straightforward: bring it into the 30 to 50 ng/mL range with 2,000 to 4,000 IU per day of D3, and recheck in 8 to 12 weeks. The case for bone-targeted supplementation during the post-GLP-1 transition is stronger for older women and for users who lost more than 15% of body weight, where the bone density signal in the GLP-1 literature is more pronounced. Adding K2 (as MK-7) at 100 to 200 mcg is reasonable if you are also raising calcium intake or have cardiovascular calcification risk factors, though the K2 evidence is more modest than the D3 evidence. See the vitamin D3 profile and the D3 with K2 profile.

Calcium, but mostly from food

For most adults, the right answer for calcium is to hit roughly 1,000 to 1,200 mg per day total intake from food (dairy, leafy greens, sardines, tofu, fortified foods). Supplemental calcium has a more complicated evidence base than vitamin D, with some studies suggesting cardiovascular risk at high supplemental doses. If food intake is genuinely low (under 600 mg/day), a 500 mg supplement to close the gap is reasonable. If food intake is already adequate, a calcium pill is not likely to add value. The calcium profile covers the form-specific differences.

Psyllium husk fiber for satiety

One practical problem in the post-GLP-1 transition is that meals stop feeling as filling. Psyllium husk (5 to 10 g before meals) has the most consistent evidence for prolonging satiety and slowing post-meal glucose excursions, both of which were doing useful work while the medication was active. This is a small effect on its own, not a substitute for the appetite suppression of the drug, but it is one of the few fiber interventions with real trial data behind it. See the psyllium husk profile.

Berberine for glycemic stability

If insulin sensitivity was an issue going into GLP-1 treatment, berberine (500 mg, 2 to 3 times daily with meals) has a modest but real effect on fasting glucose and HbA1c, working through AMPK activation. The effect size is smaller than metformin and much smaller than a GLP-1 medication, but for someone coming off a GLP-1 who wants a softer landing on the glucose side, it has the strongest natural-product evidence base. The berberine vs metformin breakdown covers the head-to-head data, and the berberine profile covers third-party testing.

Magnesium glycinate for sleep and recovery

Magnesium does not have a specific post-GLP-1 mechanism, but sleep quality matters for both appetite regulation and training recovery during the transition, and magnesium glycinate at 200 to 400 mg of elemental magnesium nightly has reasonable sleep evidence in people with subclinical deficiency (common in the US). See the magnesium glycinate profile.

What to Skip

The wellness space sells a lot of "GLP-1 alternatives" and "natural appetite suppressants" targeted at exactly this transition. The evidence is weak to absent for most of them:

Garcinia cambogia, raspberry ketones, green coffee bean extract. No quality evidence for either appetite suppression or weight maintenance. Covered in detail in our summer fat loss evidence roundup.
CLA (conjugated linoleic acid). Promising rodent data did not translate to humans. Meta-analyses show fat loss effects under half a pound over six months.
"GLP-1 boosters" or "natural Ozempic" formulas. Marketing-led product categories. The compounds inside (often a mix of berberine, chromium, gymnema, and bitter melon) have modest individual effects, and combining them in a proprietary blend does not stack the way the marketing implies.
Apple cider vinegar pills. Liquid ACV has small glucose effects. The pills do not contain enough acetic acid to replicate even that.
Thermogenic fat burners. Most rely on caffeine and stimulant blends. They do not solve the underlying problem of appetite rebound, and high stimulant intake during a transition that is already stressful for sleep and HPA axis is a poor tradeoff.

A Realistic Timeline

Most users describe the post-cessation experience in three phases:

Weeks 1 to 4. Appetite begins to return but is still suppressed. This is the window to lock in protein habits and start (or resume) resistance training before food intake fully rebounds.
Weeks 4 to 12. Appetite normalizes, gastric emptying speeds up. Calorie intake rises. Without intentional protein targets and training, this is when most regain begins. The STEP-1 extension data suggests roughly half of total regain happens in this window.
Months 3 to 12. The new baseline establishes. By month 12, most untreated patients have regained about two-thirds of the original loss. People with consistent resistance training and protein intake during the prior phases regain less and lose less muscle.

The supplements covered here will not change the broad shape of that timeline. They support muscle and bone retention during it, so that whatever weight you do keep is more favorable in composition than weight kept without them.

The Bottom Line

Coming off a GLP-1 medication is a body composition problem before it is anything else. The clinical data shows substantial weight regain on average; the supplement decisions that matter are the ones that determine whether you finish with more muscle and bone or less. Protein at 1.4 to 2.0 g per kg per day, resistance training two to three times per week, and creatine monohydrate at 5 g per day are the three highest-evidence interventions, and they are most of the answer. Vitamin D3, calcium (mostly from food), psyllium, and berberine are worth considering for specific cases. Most of the rest of the wellness "post-Ozempic" category is not supported by quality evidence.

Talk to the prescriber who originally put you on the medication before stopping or changing your protocol. Nothing here is intended as medical advice, and the timing and rate of GLP-1 discontinuation has clinical considerations that go beyond supplement choice.

Sources

Wilding JPH, Batterham RL, Davies M, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes Obes Metab. 2022;24(8):1553-1564. PMID: 35441470.
Rubino D, Abrahamsson N, Davies M, et al. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: The STEP 4 randomized clinical trial. JAMA. 2021;325(14):1414-1425. PMID: 33755728.
Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989-1002. PMID: 33567185.
Bauer J, Biolo G, Cederholm T, et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J Am Med Dir Assoc. 2013;14(8):542-559. PMID: 23867520.
Forbes SC, Candow DG, Ostojic SM, Roberts MD, Chilibeck PD. Meta-analysis examining the importance of creatine ingestion strategies on lean tissue mass and strength in older adults. Nutrients. 2021;13(6):1912. PMID: 34199420.
Antonio J, Candow DG, Forbes SC, et al. Common questions and misconceptions about creatine supplementation: what does the scientific evidence really show? J Int Soc Sports Nutr. 2021;18(1):13. PMID: 33557850.

Supplements After Stopping Ozempic: What to Take During the GLP-1 Transition